Neumora Therapeutics(NMRA) - 2025 Q4 - Earnings Call Transcript

Neumora Therapeutics (NasdaqGS:NMRA) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsAlyssa Larios - Company RepresentativeBill Aurora - Chief Operating and Development OfficerBrian Abrahams - Global Managing Director and Sector Head of Healthcare ResearchDouglas Tsao - Managing Director of Equity ResearchHelen Rubinstein - VP of Investor Relations and Corporate StrategyJosh Pinto - PresidentMike Milligan - CFONick Brandon - Chief Scientific OfficerPaul Berns - CEOPoorna Kannan - Biotec ...